Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie)

Huemer, Florian; Thaler, Josef; Piringer, Gudrun; Hackl, Hubert; Pleyer, Lisa; Hufnagl, Clemens; Weiss, Lukas; Greil, Richard

doi:10.1186/s12885-017-3955-4

BMC Cancer

Article metrics
Last updated: Fri, 19 Apr 2024 10:37:59 Z

Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie)

Access & Citations

1972

Article Accesses
10

Web of Science
12

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com